B+
Bull case
20%
Probability
Target price
$892.50
+62.0% vs current
IDXX
IDEXX LaboratoriesDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$766.00
+39.1% vs current
B-
Bear case
20%
Probability
Target price
$479.96
-12.9% vs current
AI sentiment snapshot
Latest data as of 2026-02-03
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+82.7
Score
AI commentary
Consensus is constructive: the analyst median (~$766) sits above the current anchor, implying upside if IDEXX sustains consumables growth and executes on new diagnostics [#SERP-1]. Short-term sentiment is sensitive to the next quarterly print and guidance; market views remain split on adoption timing and margin leverage [#SERP-2].
RankAlpha Sentiment AI - 2026-02-03
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-30eventQ1 2026 earnings releaseHigh impact
Earnings/date not formally announced; using company historical timing (late-April) as the assumed window end — results and guidance will drive a clearer directional move [#SERP-2].
2026-05-04catalystQ1 organic revenue and consumables growthHigh impact
Q1 results (company pattern: late-April announcement) could show recurring consumables growth and margin leverage versus expectations, providing a short-term upside catalyst [#SERP-2].
2027-02-03catalystNew diagnostic platform rollout / adoptionHigh impact
Successful commercial rollout or regulatory/technical milestones for next-gen diagnostics could materially expand addressable market and margins over the next year [#SERP-3].
Recommendation
N/A
No formal recommendation provided.
As of 2026-02-03 • Updated nightlySource: Internal modelMethodology